Circulating endothelial progenitor cells and chronic pulmonary diseases
The European Respiratory Journal
|February 2, 2011
Summary
Endothelial progenitor cells (EPCs) are crucial for vascular repair and may play a role in chronic obstructive pulmonary disease (COPD). Understanding EPCs in COPD could lead to new diagnostic and therapeutic strategies.
Area of Science:
- Cardiovascular Biology
- Pulmonary Medicine
- Cellular Biology
Background:
- Endothelial progenitor cells (EPCs) are bone marrow-derived cells vital for vascular healing and remodeling.
- Chronic obstructive pulmonary disease (COPD) involves airflow limitation, airway and lung parenchyma abnormalities, reduced exercise tolerance, and systemic inflammation.
- Endothelial dysfunction is increasingly recognized in COPD, though its causal role remains debated.
Purpose of the Study:
- To review the current understanding of EPCs in pulmonary diseases, focusing on COPD.
- To elucidate the potential role of EPCs in the pathophysiology of COPD.
- To explore the implications of EPCs for novel diagnostic and therapeutic approaches in COPD.
Main Methods:
- Literature review of studies investigating EPCs in pulmonary diseases, particularly COPD.
- Analysis of evidence linking EPCs to endothelial dysfunction in COPD.
- Synthesis of findings regarding the diagnostic and therapeutic potential of EPCs in COPD.
Main Results:
- EPCs are implicated in vascular repair and are found to be altered in various diseases.
- Evidence suggests a role for EPCs in COPD pathophysiology, potentially linked to endothelial dysfunction.
- The bone marrow, as a source of EPCs, is proposed as a potential therapeutic target in COPD.
Conclusions:
- EPCs are significant in vascular health and disease, including COPD.
- Further research into EPCs' role in COPD pathophysiology may uncover new diagnostic biomarkers.
- Targeting EPCs offers a promising avenue for developing novel therapeutic interventions for COPD.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...